Pharmamel Spin-Off biotech R&D&I biotech spin-off from the University of Granada, which holds the technology license from the Andalusian Health Service and the University of Granada for an intravenous melatonin injectable to treat sepsis (the leading cause of hospital death in the world) After conducting two Phase II clinical trials and successfully demonstrating the safety and efficacy of the drug, the company has the perfect drug candidate
Pharmamel Spin-Off biotech R&D&I biotech spin-off from the University of Granada, which holds the technology license from the Andalusian Health Service and the University of Granada for an intravenous melatonin injectable to treat sepsis (the leading cause of hospital death in the world) After conducting two Phase II clinical trials and successfully demonstrating the safety and efficacy of the drug, the company has the perfect drug candidate
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2014
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- 18009 Granada Granada
- City
- Region
- Postal Code
- 18009
- Country
- Spain